Brian Kaspar's head was at the top of the list of Novartis after company executives became aware of the fact that it was included in its application for Zolgensma, now the world's most expensive therapy.
In the first time, the scientific founder at AveXis – acquired by Novartis for $ 8.7 billion – is firing back. And he says that he is not involved in any wrongdoing, he is ready to defend his name as needed.
I reached out to Brian Kaspar after Novartis, who has been axed in mid-May, has become aware of the allegations related to manipulated data. His response came back through his attorneys.
Basic subscription required
Unlock this story instantly and join 57,500+ biopharma pros. Endpoints daily – and it's free.
Source link
https://endpts.com/avexis-scientific-founder-fires-back-at-novartis-ceo-vas-narasimhan-categorically-denies-any-wrongdoing/
